# Test Efficacy Study on the Recommended Antimalarial Drugs in the Democratic Republic of the Congo

> **NCT06076213** · PHASE4 · COMPLETED · sponsor: **Ministry of Public Health, Democratic Republic of the Congo** · enrollment: 1260 (actual)

## Conditions studied

- Uncomplicated Plasmodium Falciparum Malaria

## Interventions

- **DRUG:** Artesunate-amodiaquine
- **DRUG:** Artemether-lumefantrine

## Key facts

- **NCT ID:** NCT06076213
- **Lead sponsor:** Ministry of Public Health, Democratic Republic of the Congo
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-01
- **Primary completion:** 2024-09-24
- **Final completion:** 2024-09-30
- **Target enrollment:** 1260 (ACTUAL)
- **Last updated:** 2024-11-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06076213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06076213, "Test Efficacy Study on the Recommended Antimalarial Drugs in the Democratic Republic of the Congo". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT06076213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*